Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Placenta ; 53: 57-65, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28487022

RESUMO

INTRODUCTION: Normal placental vascular development is influenced by inflammatory, angiogenic and apoptotic processes, which may be modulated by choline through its role in membrane biosynthesis, cellular signaling and gene expression regulation. The current study examined the effect of maternal choline supplementation (MCS) on placental inflammatory, angiogenic and apoptotic processes during murine pregnancy. METHOD: Pregnant dams were randomized to receive 1, 2 or 4 times (X) the normal choline content of rodent diets, and tissues were harvested on embryonic day (E) 10.5, 12.5, 15.5 or 18.5 for gene expression, protein abundance and immunohistochemical analyses. RESULTS: The choline-induced changes in the inflammatory and angiogenic markers were a function of fetal sex. Specifically, 4X (versus 1X) choline reduced the transcript (P ≤ 0.05) and protein (P ≤ 0.06) expression of TNF-a and IL-1ß in the male placentas at E10.5 and E18.5, respectively. In the female placentas, 4X (versus 1X) choline modulated the transcript expression of Il1b in a biphasic pattern with reduced Il1b at E12.5 (P = 0.045) and E18.5 (P = 0.067) but increased Il1b at E15.5 (P = 0.031). MCS also induced an upregulation of Vegfa expression in the female placentas at E15.5 (P = 0.034; 4X versus 2X) and E18.5 (P = 0.026; 4X versus 1X). MCS decreased (P = 0.011; 4X versus 1X) placental apoptosis at E10.5. Additionally, the luminal area of the maternal spiral arteries was larger (P ≤ 0.05; 4X versus 1X) in response to extra choline throughout gestation. DISCUSSION: MCS during murine pregnancy has fetal sex-specific effects on placental inflammation and angiogenesis, with possible consequences on placental vascular development.


Assuntos
Apoptose/efeitos dos fármacos , Colina/administração & dosagem , Lipotrópicos/administração & dosagem , Neovascularização Fisiológica/efeitos dos fármacos , Placenta/efeitos dos fármacos , Animais , Biomarcadores/metabolismo , Colina/farmacocinética , Citocinas/metabolismo , Suplementos Nutricionais , Avaliação Pré-Clínica de Medicamentos , Endoglina/metabolismo , Feminino , Lipotrópicos/farmacocinética , Fígado/metabolismo , Masculino , Camundongos , Placenta/irrigação sanguínea , Placenta/imunologia , Placenta/metabolismo , Gravidez , Distribuição Aleatória , Receptor 1 de Fatores de Crescimento do Endotélio Vascular/metabolismo
2.
Curr Eye Res ; 40(3): 267-73, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24833321

RESUMO

PURPOSE: To develop a contact lens system that will control the release of an osmoprotectant and a moisturizing agent with the aim to reduce symptoms of ocular dryness. MATERIALS AND METHODS: Profiles of the release of osmoprotectant betaine and moisturizing agent dexpanthenol from senofilcon A and narafilcon B contact lenses were determined in vitro under sink conditions. Both types of lenses were also infused with vitamin E to increase the duration of drug release due to the formation of the vitamin E diffusion barriers in the lenses. The release profiles from vitamin E-infused lenses were compared with those from the control lenses. RESULTS: Both dexpanthenol and betaine are released from commercial silicone hydrogel lenses for only about 10 min. Vitamin E loadings into contact lenses at about 20-23% can increase the release times to about 10 h, which is about 60 times larger compared to the control unmodified lenses. CONCLUSIONS: Vitamin E-loaded silicone hydrogel contact lenses released betaine and dexpanthenol in a controlled fashion.


Assuntos
Betaína/farmacocinética , Lentes de Contato Hidrofílicas , Lipotrópicos/farmacocinética , Ácido Pantotênico/análogos & derivados , Vitamina E/metabolismo , Transporte Biológico Ativo , Sistemas de Liberação de Medicamentos , Síndromes do Olho Seco/tratamento farmacológico , Hidrogéis , Osmorregulação , Ácido Pantotênico/farmacocinética , Silicones , Complexo Vitamínico B/farmacocinética
3.
Food Chem Toxicol ; 46(2): 761-6, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17988777

RESUMO

Aminoalcohols differ in mammalian toxicity at least in part based upon their ability to alter the metabolism of phospholipids and to cause depletion of the essential nutrient choline in animals. This study examined the incorporation of diisopropanolamine (DIPA) into phospholipids (PLs) and effects of DIPA upon choline uptake and phospholipid synthesis in Chinese hamster ovary (CHO) cells. Results were compared to those of a related secondary alcohol amine, diethanolamine (DEA), whose systemic toxicity is closely associated with its metabolic incorporation into PLs and depletion of choline pools. DIPA caused a dose-related inhibition of (3)H-choline uptake by CHO cells that was approximately 3-4 fold less potent, based upon an IC50, than that reported for DEA. DIPA, in contrast to DEA, did not cause changes in the synthesis rates of (33)P-phosphatidylethanolamine, (33)P-phosphatidylcholine or (33)P-sphingomyelin at either non-toxic or moderately toxic concentrations. Only approximately 0.004%, of administered (14)C-DIPA was metabolically incorporated into PLs, over 30-fold less than the incorporation of (14)C-DEA under similar conditions. Overall, these data and previous pharmacokinetic and toxicity data obtained in vivo suggests that DIPA is distinct from DEA and lacks significant choline and PL metabolism related toxicity in animals.


Assuntos
Colina/farmacocinética , Etanolaminas/farmacologia , Lipotrópicos/farmacocinética , Fosfolipídeos/biossíntese , Propanolaminas/farmacologia , Animais , Células CHO , Cricetinae , Cricetulus , Interações Medicamentosas , Etanolaminas/toxicidade , Propanolaminas/toxicidade
4.
J Pharm Pharmacol ; 51(7): 847-52, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10467961

RESUMO

Choline, a precursor of the neurotransmitter acetylcholine, is synthesized in only small amounts in the brain, so the choline concentration in the brain may vary depending on the plasma concentration and the transport rate across the blood-brain barrier. To elucidate the transport mechanism of choline, we carried out uptake experiments with mouse brain capillary endothelial cells in culture (MBEC4). [3H]Choline uptake was linear for up to 5 min. An examination of the concentration dependence of [3H]choline uptake revealed the operation of both saturable (Jmax = 423+/-27 pmol min(-1) (mg protein)(-1) and Kt = 20.0+/-3.1 microM) and non-saturable (kd = 1.23+/-0.045 microL min(-1)(mgprotein)-1) processes. The saturable process was independent of Na+ and pH, but was dependent on membrane potential as a driving force. Various basic drugs and endogenous substances, including substrates and inhibitors of the organic cation transporter, significantly inhibited the [3H]choline uptake. These data suggest that choline was taken up into the endothelial cells via two routes and that a membrane potential-dependent carrier-mediated transport system may participate in choline transport across the blood-brain barrier.


Assuntos
Colina/farmacocinética , Endotélio Vascular/metabolismo , Lipotrópicos/farmacocinética , Trifosfato de Adenosina/farmacologia , Animais , Transporte Biológico/efeitos dos fármacos , Transporte Biológico/fisiologia , Encéfalo/irrigação sanguínea , Encéfalo/metabolismo , Carbonil Cianeto p-Trifluormetoxifenil Hidrazona/farmacologia , Células Cultivadas , Relação Dose-Resposta a Droga , Endotélio Vascular/citologia , Endotélio Vascular/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Concentração de Íons de Hidrogênio , Potenciais da Membrana/fisiologia , Camundongos , Compostos Orgânicos/farmacologia , Quinina/farmacologia , Azida Sódica/farmacologia , Fatores de Tempo , Trítio , Desacopladores/farmacologia
5.
FEMS Microbiol Lett ; 160(1): 25-30, 1998 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-9495008

RESUMO

Betaines were evaluated as potential antistaphylococcal agents for urinary tract infections. Staphylococcus aureus accumulated all tested betaines except trigonelline. S. aureus transport systems were less sensitive to carbon chain length than those of Escherichia coli. Betaines were accumulated in the absence of osmotic stress, and 10-fold more in hyperosmotic medium. Most betaines increased the osmotolerance of S. aureus in defined minimal medium. Unlike E. coli, S. aureus did not significantly accumulate a second betaine in the presence of glycine betaine. Betaines are less likely to be useful in treating staphylococcal than E. coli urinary infections.


Assuntos
Betaína/farmacocinética , Lipotrópicos/farmacocinética , Staphylococcus aureus/metabolismo , Antibacterianos/farmacocinética , Betaína/análogos & derivados , Meios de Cultura , Pressão Osmótica , Staphylococcus aureus/efeitos dos fármacos , Infecções Urinárias/tratamento farmacológico , Infecções Urinárias/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...